Division of Internal Medicine, Department of Biomedical, Metabolic and Neural Sciences, Azienda Ospedaliero-Universitaria, Ospedale Civile di Baggiovara, 41125 Modena, Italy.
Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, 37126 Verona, Italy.
Int J Mol Sci. 2017 Sep 12;18(9):1955. doi: 10.3390/ijms18091955.
Nonalcoholic fatty liver disease (NAFLD) is an "umbrella" definition that encompasses a spectrum of histological liver changes ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) with/without fibrosis, "cryptogenic" cirrhosis, and hepatocellular carcinoma (HCC), occurring in a dysmetabolic milieu, though in the absence of excessive alcohol consumption and other competing etiologies of chronic liver disease [1].[...].
非酒精性脂肪性肝病 (NAFLD) 是一个“伞状”定义，涵盖了一系列组织学肝脏变化，从单纯性脂肪变性到非酒精性脂肪性肝炎 (NASH) 伴/不伴纤维化、“隐源性”肝硬化和肝细胞癌 (HCC)，发生在代谢异常的环境中，但不存在过量饮酒和其他慢性肝病的竞争病因 [1]。
